CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MK0524A, niacin (+) laropiprant / Duration of Treatment: 17 Weeks - Phase 2 | MRK Pipeline | CatalystAlert